[2] [2] TIZIANA S. Clinical trials with mesenchymal stem cells: an update［J］. Cell Transplantation, 2016, 25: 829-848.

[3] [3] POLONIO A M, GARCíA-VELASCO J, HERRAIZ S. Stem cell paracrine signaling for treatment of premature ovarian insufficiency［J］. Frontiers in Endocrinology, 2021, 11: 626322.

[5] [5] WEI X, YANG X, HAN Z P, et al. Mesenchymal stem cells: a new trend for cell therapy［J］. Acta Pharmacologica Sinica, 2013, 34(6): 747-754.

[6] [6] GALDERISI U, GIORDANO A. The gap between the physiological and therapeutic roles of mesenchymal stem cells［J］. Medicinal Research Reviews, 2014, 34(5): 1100-1126.

[7] [7] GOLDRING C P, DUFFY P, BENVENISTY N, et al. Assessing the safety of stem cell therapeutics［J］. Cell Stem Cell, 2011, 9(2): 176.

[8] [8] LALU M M, MCLNTYRE L, PUGLISES C, et al. Safety of cell therapy with mesenchymal stromal cells (safe cell): a systematic review and meta-analysis of clinical trials［J］. PLoS One, 2012, 7(10): e47559.

[9] [9] VLADISLAV V, SIMOVIC M B, MARINA G, et al. Ethical and safety issues of stem cell-based therapy［J］. International Journal of Medical Sciences, 2018, 15(1): 36-45.

[10] [10] JONG S D, GAGLIARDI G, GARANTO A, et al. Implications of genetic variation in the complement system in age-related macular degeneration［J］. Progress in Retinal and Eye Research, 2021, 84(S1): 65-76.

[12] [12] FARRUKH S, BAIG S, SANI A I. Exploring modifications in fetal telomere programming in mothers exposed to multiple risk factors［J］. Current Womens Health Reviews, 2021, 17(3): 280-288.

[13] [13] KOSEBENT E G, OZTURK S. Telomere associated gene expression as well as TERT protein level and telomerase activity are altered in the ovarian follicles of aged mice［J］. Scientific Reports, 2021, 11(1): 15569.

[15] [15] NUSSBAUM J, MINAMI E, LAFLAMME M A, et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response.［J］. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 2007, 21(7): 1345-1357.

[16] [16] VALIJAM S, SALEHI A. Influence of the obstacles on dielectrophoresis-assisted separation in microfluidic devices for cancerous cells［J］. Journal of the Brazilian Society of Mechanical Sciences and Engineering, 2021, 43(3): 134.

[17] [17] PAPADOPOULOS A, CHALMANTZI V, HYVONEN M, et al. Supporting data on combined transcriptomic and phosphoproteomic analysis of BMP4 signaling in human embryonic stem cells［J］. Data in Brief, 2021, 35: 106844.

[18] [18] BLUM B, BENVENISTY N. The tumorigenicity of human embryonic stem cells［J］. Advances in Cancer Research, 2008, 100: 133-158.

[19] [19] SHANG Y, GUAN H, ZHOU F. Biological characteristics of umbilical cord mesenchymal stem cells and its therapeutic potential for hematological disorders ［J］. Frontiers in Cell and Developmental Biology, 2021, 9: 570179.

[20] [20] NAN C, XIA L, ZHOU S. Umbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation ［J］. Cellular Immunology, 2012, 274(1/2): 46-53.

[21] [21] NAVARRO A, CLOT G, PRIETO M, et al. microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics.［J］. Clinical Cancer Research, 2013, 19(12): 3121-3129.

[22] [22] MENG F, CHAI H, MA X, et al. FRET investigation toward DNA tetrahedron-based ratiometric analysis of intracellular telomerase activity［J］. Journal of Materials Chemistry B, 2019, 7(11): 1926-1932.

[23] [23] ERDEM H B, BAHSI T, ERGüN M A. Function of telomere in aging and age related diseases［J］. Environmental Toxicology and Pharmacology, 2021, 85: 103641.

[24] [24] NOURBAKHSH M, GOLESTANI A, ZAHRAI M, et al. Androgens stimulate telomerase expression, activity and phosphorylation in ovarian adenocarcinoma cells［J］. Molecular and Cellular Endocrinology, 2010, 330(1/2): 10-16.

[25] [25] SHARMA S, MUKHERJEE A, ROY S, et al. Telomerase reactivation in aggressive cancer cells: non-duplex structure formation is key to the epigenetic state of the telomerase promoter［J］. The FASEB Journal, 2021, 35(S1): 02801.

[26] [26] HINES W C. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues［J］. Molecular Cancer Research, 2005, 3(9): 503-509.

[27] [27] MENDER I, SHAY J W. Telomerase repeated amplification protocol (trap)［J］. Bio-protocol, 2011, 5(22): e1657.

[28] [28] NAGAMURA-INOUE T. Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility［J］. World Journal of Stem Cells, 2014, 6(2): 195-202.

[29] [29] KUPCZIK F, REBELATTO C, SENEGAGLIA A, et al. Human umbilical cord-derived mesenchymal stem cells or microfractures associated to a collagen matrix for bilateral knee chondral lesions repair: a clinical comparative study［J］. Cytotherapy, 2021,